Fourth quarter 2025 total revenues of approximately $69.8 million, including record net product sales of $65.4 million and contract revenues of $4.4 ...

The Schedule 1-A does not differ from the draft version issued last year, but instructions for Form 1040 provide details and ...

Discover the distinctions between cash flow and fund flow, and understand their unique uses for accountants and investors in ...

In the U.S., by contrast, a few hundred dollars a month for a relatively short period of time, typical of guaranteed-income pilots, rarely matches the steep costs of housing, child care, and health ...

About 6 million people will lose SNAP food assistance if BBCE is eliminated — more than 4 million of them, including 1.8 ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025 and ...

MYQORZO® Approved for Adults with Symptomatic Obstructive HCM in U.S., China and Europe; U.S. Launch Underway with First Prescriptions Dispensed within Days of Drug Availability Supplemental NDA for ...

MYQORZO® Approved for Adults with Symptomatic Obstructive HCM in U.S., China and Europe; U.S. Launch Underway with First Prescriptions Dispensed ...

Life insurance is a valuable tool to protect and grow a business.

One expert believes the study represents "the difference between feeling neutral and feeling genuinely seen as a person." ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...